279 related articles for article (PubMed ID: 15670187)
1. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation.
Araujo RS; Billerbeck AE; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2005 Feb; 62(2):132-6. PubMed ID: 15670187
[TBL] [Abstract][Full Text] [Related]
2. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency.
Araújo RS; Mendonca BB; Barbosa AS; Lin CJ; Marcondes JA; Billerbeck AE; Bachega TA
J Clin Endocrinol Metab; 2007 Oct; 92(10):4028-34. PubMed ID: 17666484
[TBL] [Abstract][Full Text] [Related]
3. Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency.
Zhang HJ; Yang J; Zhang MN; Zhang W; Liu JM; Wang WQ; Ning G; Li XY
Clin Endocrinol (Oxf); 2009 Feb; 70(2):201-7. PubMed ID: 18702679
[TBL] [Abstract][Full Text] [Related]
4. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
[TBL] [Abstract][Full Text] [Related]
5. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
6. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
7. The distribution of intrafamilial CYP21A2 mutant alleles and investigation of clinical features in Turkish children and their siblings in Southeastern Anatolia.
Karaoglan M
J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1311-1320. PubMed ID: 31693496
[TBL] [Abstract][Full Text] [Related]
8. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
[TBL] [Abstract][Full Text] [Related]
11. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.
Grigorescu Sido A; Weber MM; Grigorescu Sido P; Clausmeyer S; Heinrich U; Schulze E
J Clin Endocrinol Metab; 2005 Oct; 90(10):5769-73. PubMed ID: 16046588
[TBL] [Abstract][Full Text] [Related]
12. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between variants of CYP21A2 gene promoter region and nonclassical 21-hydroxylase deficiency].
Huang S; Su Z; Zhang L; Zhao X; Wen P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):815-818. PubMed ID: 32761585
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kocova M; Anastasovska V; Falhammar H
Endocrine; 2020 Aug; 69(2):262-277. PubMed ID: 32367336
[TBL] [Abstract][Full Text] [Related]
15. Association of p.His38Leu, a rare CYP21A2 mutation, with the classical simple virilizing phenotype of 21-hydroxylase deficiency in a 6-year-old boy.
Oriola J; Bosch MZ; Valls C; Ibáñez L
Horm Res Paediatr; 2011; 76(3):214-7. PubMed ID: 21912141
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
[TBL] [Abstract][Full Text] [Related]
17. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.
Krone N; Braun A; Roscher AA; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2000 Mar; 85(3):1059-65. PubMed ID: 10720040
[TBL] [Abstract][Full Text] [Related]
18. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
Torres N; Mello MP; Germano CM; Elias LL; Moreira AC; Castro M
Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.
Tardy V; Menassa R; Sulmont V; Lienhardt-Roussie A; Lecointre C; Brauner R; David M; Morel Y
J Clin Endocrinol Metab; 2010 Mar; 95(3):1288-300. PubMed ID: 20080860
[TBL] [Abstract][Full Text] [Related]
20. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
